Abstract
BACKGROUND Genetic risk modeling for dementia offers significant benefits, but studies based on real-world data, particularly for underrepresented populations, are limited.
METHODS We employed an Elastic Net model for dementia risk prediction using single-nucleotide polymorphisms prioritized by functional genomic data from multiple neurodegenerative disease genome-wide association studies. We compared this model with APOE and polygenic risk score models across genetic ancestry groups, using electronic health records from UCLA Health for discovery and All of Us cohort for validation.
RESULTS Our model significantly outperforms other models across multiple ancestries, improving the area-under-precision-recall curve by 21-61% and the area-under-the-receiver-operating characteristic by 10-21% compared to the APOE and the polygenic risk score models. We identified shared and ancestry-specific risk genes and biological pathways, reinforcing and adding to existing knowledge.
CONCLUSIONS Our study highlights benefits of integrating functional mapping, multiple neurodegenerative diseases, and machine learning for genetic risk models in diverse populations. Our findings hold potential for refining precision medicine strategies in dementia diagnosis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
MF, LVB, SSW, and TSC was supported by the National Institutes of Health (NIH) National Institute of Aging (NIA) grant K08AG065519-01A1 and the Fineberg Foundation. KV was supported by NIH grants R01 NS033310, R01 AG058820, R01 AG075955, and R56 AG074473. BP was supported by NIH grants R01HG009120, R01MH115676, and R01HG006399.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
As all genetic data and EHRs utilized in this study were de-identified, the study was deemed exempt from human subject research regulations (UCLA IRB# 21-000435).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
6 List of abbreviations
- AA
- African American
- AD
- Alzheimer’s disease
- APOE
- Apolipoprotein E
- AUPRC
- Area Under the Precision-Recall Curve
- AUROC
- area under the receiver operating characteristic
- CADD
- Combined Annotation-Dependent Depletion
- CI
- confidence intervals
- EA
- European American
- EAA
- East Asian American
- EHR
- Electronic Health Records
- FTD
- Frontotemporal dementia
- FUMA
- Functional Mapping and Annotation of Genome-Wide Association Studies
- GIA
- Genetic Inferred Ancestry
- GO
- Gene Ontology
- GWAS
- Genome-Wide Association Studies
- HLA
- Hispanic Latino American
- LBD
- Lewy body dementia
- LD
- Linkage disequilibrium
- MCC
- Matthews Correlation Coefficient
- PC
- principal components
- PDD
- Parkinson’s disease dementia
- PRS
- Polygenic risk scores
- SAA
- South Asian American
- SNP
- Single-Nucleotide Polymorphisms
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.